Hologic Financial Statements From 2010 to 2024
| HO1 Stock | EUR 69.00 0.50 0.73% |
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as , as well as many indicators such as . Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
Hologic |
Hologic Company Profit Margin Analysis
Hologic's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Hologic Profit Margin | 0.22 % |
Most of Hologic's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hologic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Hologic has a Profit Margin of 0.2217%. This is 101.98% lower than that of the Healthcare sector and 101.23% lower than that of the Medical Instruments & Supplies industry. The profit margin for all Germany stocks is 117.46% lower than that of the firm.
Hologic Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hologic's current stock value. Our valuation model uses many indicators to compare Hologic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hologic competition to find correlations between indicators driving Hologic's intrinsic value. More Info.Hologic is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hologic is roughly 2.40 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hologic's earnings, one of the primary drivers of an investment's value.About Hologic Financial Statements
Hologic stakeholders use historical fundamental indicators, such as Hologic's revenue or net income, to determine how well the company is positioned to perform in the future. Although Hologic investors may analyze each financial statement separately, they are all interrelated. For example, changes in Hologic's assets and liabilities are reflected in the revenues and expenses on Hologic's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Hologic, Inc., a medical technology company, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company was founded in 1985 and is headquartered in Marlborough, Massachusetts. HOLOGIC INC is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Hologic Stock
When determining whether Hologic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hologic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hologic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hologic Stock:Check out the analysis of Hologic Correlation against competitors. For more detail on how to invest in Hologic Stock please use our How to Invest in Hologic guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.